Skip to main content

Table 1 Averaged area under the ROC curve (AUC) and coefficient of determination (R 2 probit ), as well standard deviations (between parenthesis), obtained from the testing sets in the 10 fold-crossvalidation analyses of time to first recurrence (TFR) and time to progression in the whole (TP), high risk (TPHiR) and low risk (TPLR) cohorts

From: Prediction of non-muscle invasive bladder cancer outcomes assessed by innovative multimarker prognostic models

Model

Criterion

TFR

TP

TPHiR

TPLR

  

Whole series

Whole series

HiR tumors

LR tumors

CPP

AUC

0.62 (0.05)

0.76 (0.09)

0.57 (0.04)

0.45 (0.02)

 

R 2 probit

0.031 (0.004)

0.054 (0.013)

0.151 (0.013)

0.0358 (0.0094)

SNPs

AUC

0.55 (0.02)

0.58 (0.09)

0.56 (0.01)

0.55 (0.01)

 

R 2 probit

0.010 (0.001)

0.001 (0.000)

0.009 (0.002)

0.0005 (0.0002)

CPP&SNPs

AUC

0.61 (0.05)

0.76 (0.10)

0.57 (0.03)

0.47 (0.02)

 

R 2 probit

0.041 (0.006)

0.050 (0.013)

0.155 (0.019)

0.0267 (0.0099)

  1. CPP clinico-pathological prognosticators